134 related articles for article (PubMed ID: 15648950)
1. Novel radiosensitizers for tumors of the central nervous system.
Mehta MP; Suh JH
Curr Opin Investig Drugs; 2004 Dec; 5(12):1284-91. PubMed ID: 15648950
[TBL] [Abstract][Full Text] [Related]
2. Radiation sensitization with redox modulators: a promising approach.
Rosenberg A; Knox S
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):343-54. PubMed ID: 16414370
[TBL] [Abstract][Full Text] [Related]
3. Motexafin gadolinium: a novel radiosensitizer for brain tumors.
Francis D; Richards GM; Forouzannia A; Mehta MP; Khuntia D
Expert Opin Pharmacother; 2009 Sep; 10(13):2171-80. PubMed ID: 19640206
[TBL] [Abstract][Full Text] [Related]
4. Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumors.
Khuntia D; Mehta M
Expert Rev Anticancer Ther; 2004 Dec; 4(6):981-9. PubMed ID: 15606327
[TBL] [Abstract][Full Text] [Related]
5. Motexafin gadolinium: a novel radiosensitizer for brain tumors.
Forouzannia A; Richards GM; Khuntia D; Mehta MP
Expert Rev Anticancer Ther; 2007 Jun; 7(6):785-94. PubMed ID: 17555388
[TBL] [Abstract][Full Text] [Related]
6. Chemical radiosensitizers for use in radiotherapy.
Wardman P
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
[TBL] [Abstract][Full Text] [Related]
7. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
Suh JH; Stea B; Nabid A; Kresl JJ; Fortin A; Mercier JP; Senzer N; Chang EL; Boyd AP; Cagnoni PJ; Shaw E
J Clin Oncol; 2006 Jan; 24(1):106-14. PubMed ID: 16314619
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
9. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
Guichard M; Malaise EP
Sem Hop; 1980 Jun 8-15; 56(21-24):1094-107. PubMed ID: 6156491
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs.
Chen AY; Chou R; Shih SJ; Lau D; Gandara D
Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660
[TBL] [Abstract][Full Text] [Related]
11. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
Guichard M; Malaise EP
Pathol Biol (Paris); 1980 Jan; 28(1):29-42. PubMed ID: 6153787
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme.
Chang JE; Khuntia D; Robins HI; Mehta MP
Clin Adv Hematol Oncol; 2007 Nov; 5(11):894-902, 907-15. PubMed ID: 18185489
[TBL] [Abstract][Full Text] [Related]
13. Combining etoposide and dexrazoxane synergizes with radiotherapy and improves survival in mice with central nervous system tumors.
Hofland KF; Thougaard AV; Dejligbjerg M; Jensen LH; Kristjansen PE; Rengtved P; Sehested M; Jensen PB
Clin Cancer Res; 2005 Sep; 11(18):6722-9. PubMed ID: 16166453
[TBL] [Abstract][Full Text] [Related]
14. Non-cytotoxic radiosensitizers in brain radiotherapy: journey till the first decade of this millennium.
Mohindra P; Sinha RN; Andrews RJ; Khuntia D
Curr Cancer Drug Targets; 2012 Mar; 12(3):260-78. PubMed ID: 22268387
[TBL] [Abstract][Full Text] [Related]
15. Efaproxiral: a radiation enhancer used in brain metastases from breast cancer.
Charpentier MM
Ann Pharmacother; 2005 Dec; 39(12):2038-45. PubMed ID: 16249270
[TBL] [Abstract][Full Text] [Related]
16. Advances in the management of pediatric central nervous system tumors.
Abdullah S; Qaddoumi I; Bouffet E
Ann N Y Acad Sci; 2008 Sep; 1138():22-31. PubMed ID: 18837879
[TBL] [Abstract][Full Text] [Related]
17. Role of efaproxiral in metastatic brain tumors.
Engel RH; Kaklamani VG
Expert Rev Anticancer Ther; 2006 Apr; 6(4):477-85. PubMed ID: 16613536
[TBL] [Abstract][Full Text] [Related]
18. Sulfoglycolipids as candidate antiangiogenic radiosensitizers.
Miura M; Sakimoto I; Ohta K; Sugawara F; Sakaguchi K
Anticancer Drugs; 2007 Jan; 18(1):1-5. PubMed ID: 17159496
[TBL] [Abstract][Full Text] [Related]
19. Role and relevance of neurocognitive assessment in clinical trials of patients with CNS tumors.
Meyers CA; Brown PD
J Clin Oncol; 2006 Mar; 24(8):1305-9. PubMed ID: 16525186
[TBL] [Abstract][Full Text] [Related]
20. Pediatric CNS tumors: current treatment and future directions.
Hargrave DR; Zacharoulis S
Expert Rev Neurother; 2007 Aug; 7(8):1029-42. PubMed ID: 17678498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
